JNJ

226.9

+1.03%↑

ABT

105.67

-1.67%↓

MDT

100.65

+0.22%↑

A

134.19

-1.16%↓

VEEV

217.19

-0.76%↓

JNJ

226.9

+1.03%↑

ABT

105.67

-1.67%↓

MDT

100.65

+0.22%↑

A

134.19

-1.16%↓

VEEV

217.19

-0.76%↓

JNJ

226.9

+1.03%↑

ABT

105.67

-1.67%↓

MDT

100.65

+0.22%↑

A

134.19

-1.16%↓

VEEV

217.19

-0.76%↓

JNJ

226.9

+1.03%↑

ABT

105.67

-1.67%↓

MDT

100.65

+0.22%↑

A

134.19

-1.16%↓

VEEV

217.19

-0.76%↓

JNJ

226.9

+1.03%↑

ABT

105.67

-1.67%↓

MDT

100.65

+0.22%↑

A

134.19

-1.16%↓

VEEV

217.19

-0.76%↓

Search

Intuitive Surgical Inc

Deschisă

SectorSănătate

521.19 -0.87

Rezumat

Modificarea prețului

24h

Curent

Minim

520

Maxim

528.83

Indicatori cheie

By Trading Economics

Venit

45M

709M

Vânzări

361M

2.9B

P/E

Medie Sector

67.108

90.422

Marjă de profit

28.31

Angajați

15,638

EBITDA

-60M

956M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+24.32% upside

Dividende

By Dow Jones

Următoarele câștiguri

21 apr. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-2.2B

190B

Deschiderea anterioară

522.06

Închiderea anterioară

521.19

Sentimentul știrilor

By Acuity

26%

74%

54 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bearish Evidence

Intuitive Surgical Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

21 oct. 2025, 23:55 UTC

Acțiuni populare

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 oct. 2025, 21:14 UTC

Câștiguri
Principalele dinamici ale pieței

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 oct. 2025, 20:38 UTC

Câștiguri

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 iul. 2025, 21:13 UTC

Câștiguri

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

23 ian. 2026, 16:07 UTC

Câștiguri

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

23 ian. 2026, 12:58 UTC

Câștiguri

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

22 ian. 2026, 21:11 UTC

Câștiguri

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 ian. 2026, 21:11 UTC

Câștiguri

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 ian. 2026, 21:10 UTC

Câștiguri

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 ian. 2026, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q EPS $2.21 >ISRG

22 ian. 2026, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q Rev $2.87B >ISRG

22 ian. 2026, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q Net $794.8M >ISRG

22 ian. 2026, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

22 ian. 2026, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

30 oct. 2025, 12:38 UTC

Câștiguri

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 oct. 2025, 12:01 UTC

Câștiguri

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 oct. 2025, 15:42 UTC

Câștiguri

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 oct. 2025, 12:34 UTC

Câștiguri

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 oct. 2025, 11:49 UTC

Câștiguri

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 oct. 2025, 20:08 UTC

Câștiguri

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 oct. 2025, 20:08 UTC

Câștiguri

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 oct. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 oct. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 3Q Net $704.4M >ISRG

21 oct. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 oct. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 oct. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 iul. 2025, 20:14 UTC

Câștiguri

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 iul. 2025, 20:13 UTC

Câștiguri

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 iul. 2025, 20:13 UTC

Câștiguri

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 iul. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 2Q Net $658.4M >ISRG

Comparație

Modificare preț

Intuitive Surgical Inc Așteptări

Obiectiv de preț

By TipRanks

24.32% sus

Prognoză pe 12 luni

Medie 652.73 USD  24.32%

Maxim 750 USD

Minim 550 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruIntuitive Surgical Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

18 ratings

14

Cumpărare

4

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

514.59 / 539.05Suport & Rezistență

Termen scurt

Weak Bearish Evidence

Termen mediu

Weak Bullish Evidence

Termen lung

Strong Bullish Evidence

Sentiment

By Acuity

54 / 352 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat